U.S. market Closed. Opens in 1 day 6 hours 38 minutes

EFTR | eFFECTOR Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/A3.55M1.43M42.00MN/A
Cost of Revenue22.92M53.00K24.00K21.83M307.00K
Gross Profit-22.92M3.50M1.41M20.17M-307.00K
Operating Expenses33.84M32.40M31.90M26.18M28.30M
Selling, General & Admin10.93M12.64M13.37M4.35M4.71M
Research & Development22.92M23.31M19.96M21.83M23.58M
Other Operating ExpensesN/A-3.55M-1.43M9.00KN/A
Operating Income-33.84M-32.40M-31.90M15.82M-28.61M
Other Expenses / Income-1.97M9.74M47.70M-1.26M-1.13M
Before Tax Income-35.81M-22.66M15.80M14.56M-29.74M
Income Tax ExpensesN/A-9.74M-24.00K351.00K135.14K
Net Income-35.81M-12.93M15.80M14.21M-29.74M
Interest ExpensesN/A2.25M1.76M1.33M1.38M
Basic Shares Outstanding2.19M1.65M1.62M598.56K552.43K
Diluted Shares Outstanding2.19M1.65M1.62M598.56K552.43K
EBITDA-33.73M-32.40M-31.90M16.05M-28.30M
EBITDA Margin0.00%-911.99%-2,230.56%38.23%0.00%
EBIT-35.81M-20.41M17.54M15.89M-28.22M
EBIT Margin0.00%-574.56%1,226.43%37.85%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙